Rubius Therapeutics (STU:5RT) Total Liabilities : €7.49 Mil (As of Dec. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Total Liabilities?

Rubius Therapeutics's Total Liabilities for the quarter that ended in Dec. 2022 was €7.49 Mil.

Rubius Therapeutics's quarterly Total Liabilities increased from Jun. 2022 (€126.33 Mil) to Sep. 2022 (€135.45 Mil) but then declined from Sep. 2022 (€135.45 Mil) to Dec. 2022 (€7.49 Mil).

Rubius Therapeutics's annual Total Liabilities increased from Dec. 2020 (€111.98 Mil) to Dec. 2021 (€123.23 Mil) but then declined from Dec. 2021 (€123.23 Mil) to Dec. 2022 (€7.49 Mil).

Rubius Therapeutics Total Liabilities Historical Data

The historical data trend for Rubius Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Total Liabilities Chart

Rubius Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

75.68

108.57

111.98

123.23

7.49

Rubius Therapeutics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Total Liabilities	Get a 7-Day Free Trial															123.23	120.29	126.33	135.45	7.49

Rubius Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Rubius Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.494	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.49

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	21.778	-	14.284
	=	7.49

Rubius Therapeutics's Total Liabilities for the quarter that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.494	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.49

Total Liabilities	=	Total Assets (Q: Dec. 2022 )	-	Total Equity (Q: Dec. 2022 )
	=	21.778	-	14.284
	=	7.49

Rubius Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Washington Street, Suite 101, Foxborough, MA, USA, 02035

Website

https://www.rubiustx.com

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines